Biostem Technologies Inc
OTC:BSEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biostem Technologies Inc
OTC:BSEM
|
US |
|
First Shanghai Investments Ltd
HKEX:227
|
HK |
|
Pivotal Systems Corp
ASX:PVS
|
US |
|
VeriSilicon Microelectronics Shanghai Co Ltd
SSE:688521
|
CN |
|
Catalyst Metals Ltd
ASX:CYL
|
AU |
|
Multipolar Technology Tbk PT
IDX:MLPT
|
ID |
|
Red Sea International Company SJSC
SAU:4230
|
SA |
|
Itway SpA
MIL:ITW
|
IT |
|
I
|
INNOX Advanced Materials Co Ltd
KOSDAQ:272290
|
KR |
|
T
|
TQR PCL
SET:TQR
|
TH |
|
Nusco SpA
MIL:NUS
|
IT |
|
Rapid7 Inc
NASDAQ:RPD
|
US |
|
S
|
SWK Holdings Corp
NASDAQ:SWKH
|
US |
|
Relief Therapeutics Holding SA
SIX:RLF
|
CH |
|
Precia SA
PAR:PREC
|
FR |
|
Piraeus Financial Holdings SA
ATHEX:TPEIR
|
GR |
Bankruptcy Probability
Biostem Technologies Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biostem Technologies Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Biostem Technologies Inc
OTC:BSEM
|
86.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
887.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
233.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
88.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biostem Technologies Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biostem Technologies Inc has no debt.
You can find a full breakdown on its Balance Sheet.
